Global Health Partnerships The Pharmaceutical Industry and BRICA

by Wang, Mei-Ling; Zhang, Shuo; Wang, Xiaowan

• ISBN13: 9780230515604
• ISBN10: 0230515606
• Format: Hardcover
• Copyright: 2009-01-15
• Publisher: Palgrave Macmillan

Summary

Global Health, Pharmaceutical Industry and BRICexplores the status and future growth of the global pharmaceutical industry and the changing needs of global health. Brazil, Russia, and China combined will be the largest pharmaceutical producer and has the largest pharmaceutical market potential in the world. This book fulfiles the need for a comprehensive book on the role of the global pharmecutical industry in general, and the participation of BRIC in specific to address global health needs.

Author Biography

MEI LING WANG is Associate Professor of Social Sciences and Health Policy at the University of the Sciences in Philidelphia, USA. She studied at the Harvard School of Public Health and has devoted her career to writing on global issues.

SHUO ZHANG works for DSS VHA, in Texas, USA and has been at the frontline of China's health system.

XIAO-WAN WANG is Professor of Health Economics at the school of Public Health, Central South University, China. He has first hand experience of working in China's health system as an academic and policy analyst.

Table of Contents

Acknowledgments	p. ix
Global Health Partnerships: An Introduction	p. 1
Global health challenges	p. 1
Solutions: types and components	p. 10
Major issues in global pharmaceutical provision	p. 12
Pharmaceutical research and development	p. 15
Global demand.for Pharmaceuticals	p. 29
The Modern Pharmaceutical Industry: History, Current Position and Challenges	p. 33
Drug development	p. 34
The history of large pharmaceutical companies	p. 36
Regulatory environment	p. 38
Pharmaceutical companies	p. 43
Large pharmas and R&D	p. 50
Large pharmas' profit profile	p. 57
Outsiders' perception of the pharmaceutical sector	p. 62
Challenges facing the multinational pharmaceutical industry	p. 73
Summary	p. 78
BRICA in Global Pharmaceutical Provision	p. 81
BRICA: The emerging economic powers	p. 81
Economic prowess	p. 86
BRICA's Pharmaceutical Industry	p. 94
Global Health Partnerships between Multinationals and BRICA: A Planting Strategy	p. 133
Planting strategy versus plucking strategy	p. 134
The promise of planting	p. 135
Innovation	p. 135
Cost control	p. 138
Quality control	p. 142
Collaboration against counterfeits	p. 147
The fundamental solution	p. 153
Division of labor	p. 161
Conclusion	p. 163
References	p. 167
Index	p. 189
Table of Contents provided by Ingram. All Rights Reserved.